Precision Medicine and Machine Learning to predict critical disease and death due to Coronavirus disease 2019 (COVID-19).

Journal: Human immunology
Published Date:

Abstract

INTRODUCTION: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes Coronavirus Disease 2019 (COVID-19) and induces activation of inflammatory pathways, including the inflammasome.

Authors

  • Walton Luiz Del Tedesco Júnior
    Infectious Diseases Unit, Department of Clinical Medicine, Health Sciences Center, State University of Londrina, Londrina, Paraná, Brazil. Electronic address: drwaltontedesco@gmail.com.
  • Tiago Danelli
    Infectious Diseases Unit, Department of Clinical Medicine, Health Sciences Center, State University of Londrina, Londrina, Paraná, Brazil. Electronic address: tiago.danelli2019@uel.br.
  • Zuleica Naomi Tano
    Infectious Diseases Unit, Department of Clinical Medicine, Health Sciences Center, State University of Londrina, Londrina, Paraná, Brazil. Electronic address: zntanno@terra.com.br.
  • Pedro Luis Candido de Souza Cassela
    Laboratory of Research in Applied Immunology, University Hospital of Londrina, University of Londrina, Londrina, Paraná, Brazil. Electronic address: pedro.luis.candido@uel.br.
  • Guilherme Lerner Trigo
    Laboratory of Research in Applied Immunology, University Hospital of Londrina, University of Londrina, Londrina, Paraná, Brazil. Electronic address: guilherme.lerner@uel.br.
  • Kauê de Morais Cardoso
    Laboratory of Research in Applied Immunology, University Hospital of Londrina, University of Londrina, Londrina, Paraná, Brazil. Electronic address: kaue.moraiscardoso@uel.br.
  • Livia Padovam Loni
    Laboratory of Research in Applied Immunology, University Hospital of Londrina, University of Londrina, Londrina, Paraná, Brazil. Electronic address: livia.padovam.loni@uel.br.
  • Tainah Mendes Ahrens
    Laboratory of Research in Applied Immunology, University Hospital of Londrina, University of Londrina, Londrina, Paraná, Brazil. Electronic address: tainah.m.ahrens@uel.br.
  • Beatriz Rabello Espinosa
    Laboratory of Research in Applied Immunology, University Hospital of Londrina, University of Londrina, Londrina, Paraná, Brazil. Electronic address: beatriz.rabello@uel.br.
  • Alvaro Jungblut Fernandes
    Laboratory of Research in Applied Immunology, University Hospital of Londrina, University of Londrina, Londrina, Paraná, Brazil. Electronic address: alvaro.fernandesmd@uel.br.
  • Elaine Regina Delicato de Almeida
    Laboratory of Research in Applied Immunology, University Hospital of Londrina, University of Londrina, Londrina, Paraná, Brazil; Department of Pathology, Clinical Analysis and Toxicology, Health Sciences Center, University of Londrina, Londrina, Paraná, Brazil. Electronic address: elainedelicato@uel.br.
  • Marcell Alysson Batisti Lozovoy
    Department of Pathology, Clinical Analysis and Toxicology, University of Londrina, Londrina, Parana, Brazil.
  • Edna Maria Vissoci Reiche
    Department of Pathology, Clinical Analysis and Toxicology, Health Sciences Center, University Hospital, State University of Londrina, Av. Robert Koch 60, Londrina, Paraná, CEP 86038-350, Brazil. reiche@sercomtel.com.br.
  • Michael Maes
    Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Andrea Name Colado Simão
    Department of Pathology, Clinical Analysis and Toxicology, University of Londrina, Londrina, Parana, Brazil.

Keywords

No keywords available for this article.